This Overlooked Spin-Off Just Landed on the Market with Big Upside Potential
If you’re hunting for a stock that combines real-world demand with deep value potential, forget tech for a minute and take a closer look at this industrial name flying under Wall Street’s radar.
Amrize (NYSE: ARZ) is a recent spin-off from global cement leader Holcim — and most investors still haven’t caught on. But now that it’s trading independently, this under-the-radar company could become one of the most compelling value plays of the summer.
Why You Haven’t Heard of Amrize
Spinoffs tend to fly below the radar. Big institutional investors often wait to build positions, and smaller names can get lost in the shuffle when separated from a large global parent.
That’s exactly what happened with Amrize. Previously Holcim’s North American business, it now operates as a standalone provider of cement, aggregates, asphalt, and commercial roofing materials across the U.S. and Canada.
This isn’t a flashy growth story built on future hope — it’s a real business built on roads, bridges, and commercial rooftops. And it’s happening right now.
The Numbers Are Strong
-
Management is targeting 5–8% annual revenue growth and 8–11% EBITDA growth through 2028.
-
The company expects to generate over $8 billion in free cash flow over the next four years.
-
RBC Capital Markets has already slapped a $60 price target on the stock — about 20% upside from where it trades today.
-
Despite solid fundamentals, Amrize is trading at a discount to peers like Martin Marietta and Vulcan Materials.
That disconnect — strong cash flow, institutional support, and low valuation — creates an opportunity.
A Summer Catalyst
Timing matters. Summer is peak season for construction and infrastructure work. State and local governments are spending heavily, and commercial projects are ramping back up.
That’s good news for Amrize, which operates in materials essential to those projects — cement, aggregates, and asphalt. Add in roofing systems for commercial buildings, and you’ve got a company positioned to benefit from a real, seasonal tailwind.
And let’s not forget the impact of the infrastructure bills passed over the last few years. That money is still flowing into the economy — and companies like Amrize are where the rubber meets the road.
Why It’s Still Undervalued
Spinoffs often get mispriced early. Index funds are still adjusting. Institutions haven’t fully built positions. And analysts are still updating models.
That’s where patient investors can take advantage. Amrize already has:
-
Real revenue
-
Established customer relationships
-
Pricing power in essential markets
-
A leadership team with public market experience
Plus, it may eventually initiate a dividend or begin buybacks as cash flow ramps — adding more appeal for value-focused investors.
Final Take
If you’re looking to add a high-quality industrial name to your portfolio — one with real assets, healthy margins, and a clear path to cash generation — Amrize deserves a closer look.
Wall Street may not be paying attention yet, but that’s exactly why it’s worth considering now.
